Alumis (ALMS) Cash from Financing Activities (2023 - 2025)

Alumis (ALMS) reported Cash from Financing Activities of $1.3 million for Q4 2025, up 26260.0% year-over-year from N/an in Q4 2024, and up 26260.0% quarter-over-quarter from $5000.0 in Q4 2024.

Alumis (ALMS) Cash from Financing Activities (2023 - 2025) Analysis & Trends

Alumis (ALMS) has 3 years of Cash from Financing Activities data on file, last reported at $1.3 million in Q4 2025.

  • Cash from Financing Activities for Q4 2025 came in at $1.3 million, up 26260.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $236.5 million (down 51.97% YoY), and the FY2025 annual result was $2.1 million, down 99.58% from the prior year.
  • Cash from Financing Activities rose to $1.3 million in Q4 2025 per ALMS's latest filing, from $5000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $235.2 million in Q3 2024 and troughed at $5000.0 in Q4 2024.
  • A 3-year average of $74.8 million and a median of $29.7 million in 2023 frame the typical range for Cash from Financing Activities.
  • On a YoY basis, Cash from Financing Activities climbed as much as 500221.28% in 2024 and fell as far as 99.98% in 2024.
  • A 3-year view of Cash from Financing Activities shows it stood at $29.7 million in 2023, then slumped by 99.98% to $5000.0 in 2024, then jumped by 26260.0% to $1.3 million in 2025.
  • Business Quant data shows ALMS's Cash from Financing Activities at $1.3 million in Q4 2025, $5000.0 in Q4 2024, and $235.2 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Alumis 1.99 Bn 1.90 Bn - 1.32 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.32 Mn
Dec 31, 2025 1.32 Mn
Dec 31, 2024 5,000.00
Dec 31, 2024 5,000.00
Sep 30, 2024 235.15 Mn
Sep 30, 2024 235.15 Mn
Jun 30, 2024 128.06 Mn
Jun 30, 2024 128.06 Mn
Mar 31, 2024 129.15 Mn
Mar 31, 2024 129.15 Mn
Dec 31, 2023 29.72 Mn
Dec 31, 2023 29.72 Mn
Sep 30, 2023 47,000.00
Sep 30, 2023 47,000.00